What is CARDIOX?
CARDIOX operates at the intersection of artificial intelligence and biosensing, offering a sophisticated platform designed to provide real-time insights into cardiovascular, metabolic, and behavioral health. By integrating multiple sensing modalities, the company delivers advanced metrics such as cuffless blood pressure, hydration levels, and stress monitoring. Its adaptable technology serves a diverse clientele, including sports teams, fitness centers, healthcare providers, researchers, and corporate wellness programs, aiming to enhance performance, patient engagement, and research outcomes through comprehensive health data.
How much funding has CARDIOX raised?
CARDIOX has raised a total of $12.6M across 4 funding rounds:
Private Equity
$786K
Debt
$652K
Private Equity
$8M
Unspecified
$3.2M
Private Equity (2009): $786K, investors not publicly disclosed
Debt (2010): $652K, investors not publicly disclosed
Private Equity (2011): $8M, investors not publicly disclosed
Unspecified (2014): $3.2M featuring Reservoir Venture Partners and Early Stage Partners
Key Investors in CARDIOX
Reservoir Venture Partners
Reservoir Venture Partners is a venture capital firm operating within the venture capital and private equity industry, likely focusing on strategic investments in technology-driven companies.
Early Stage Partners
Early Stage Partners is a venture capital firm established in 2001, focused on supporting technology companies in the Midwest, providing capital and strategic guidance to early-stage ventures.
What's next for CARDIOX?
With the recent major strategic investment, CARDIOX is poised for accelerated development and market expansion. The substantial enterprise-level funding suggests a focus on scaling operations, enhancing its AI capabilities, and broadening its service offerings to a wider array of clients. Future strategic moves are likely to involve deeper integration into healthcare ecosystems and further refinement of its biosensing technology to address evolving health and wellness demands. The company's trajectory indicates a strong push towards becoming a leader in the preventative and personalized health technology sector.
See full CARDIOX company page
